Cymbiotika NMN Review (2026): The Highest Trust Score in NMN, but Is It Worth $77?

Who Is Cymbiotika?

Cymbiotika is a San Diego-based supplement company that positions itself in the premium "clean wellness" category. Founded in 2018, the brand has built a portfolio of over 35 products across longevity, gut health, cognitive support, and beauty categories. Their average product price is ~$63, placing them firmly in the luxury supplement tier alongside brands like Thorne and Momentous.

What separates Cymbiotika from most NMN competitors is not the NMN itself but the infrastructure around it. The brand holds USDA Organic, Non-GMO Project, and Gluten-Free certifications across its product line. Its NMN product carries ISO 17025-accredited third-party testing and NSF-certified manufacturing, two verification standards that the majority of Amazon-based NMN brands cannot demonstrate. SuppCo's brand-level TrustScore for Cymbiotika is 9.05 (Elite tier), and the NMN product specifically scores 9.63, the single highest TrustScore in the entire NMN supplement category.

This is a company that has invested heavily in the credentialing infrastructure that the longevity supplement space largely lacks. The question this review answers is whether that infrastructure justifies the price, and whether the formula itself delivers value proportional to the premium.

Breaking Down the Supplement Facts Panel

The formula contains five active ingredients per two-capsule serving. Each requires individual evaluation against clinical evidence.

Ingredient	Dose per Serving	Clinical Range	Verdict
NMN (Nicotinamide Mononucleotide)	400 mg	250-1,250 mg	Within range but below 500 mg standard
Apigenin 98%	200 mg	50-500 mg (limited human data)	Reasonable, though few controlled trials exist
Green Tea Extract (20% L-Theanine)	200 mg (= ~40 mg L-theanine)	100-400 mg L-theanine for cognitive effects	L-theanine content sub-clinical
Trans-Resveratrol 98%	100 mg	150-500 mg	Below most trial doses
Green Coffee Bean (10% Caffeine)	100 mg (= ~10 mg caffeine)	400-800 mg chlorogenic acid	Trace dose, minimal physiological impact

NMN at 400 mg: Clinically Relevant or a Compromise?

Cymbiotika's 400 mg NMN dose sits in the clinically tested range (250-1,250 mg), so it is not subtherapeutic. The landmark Yoshino trial published in Science demonstrated meaningful metabolic improvements at just 250 mg daily in prediabetic women (Yoshino et al., 2021, PMID: 33888596), and Igarashi showed elevated NAD+ and improved walking speed in older men at the same dose (Igarashi et al., 2022, PMID: 35927255).

However, the dose-ranging trial by Yi and colleagues found that 600 mg and 900 mg produced the highest NAD+ elevations, with 300 mg showing a weaker response (Yi et al., 2023, PMID: 36482258). At 400 mg, Cymbiotika lands between the 300 mg and 600 mg dose tiers. You are likely getting meaningful NAD+ elevation but not maximizing the dose-response curve the way a 500 mg or 600 mg product would.

For a product priced at $2.57/day, this creates an unusual value proposition. Competitors like Nutricost deliver 500 mg for $0.90/day, and Force Factor delivers 500 mg for $0.83/day. On a cost-per-milligram basis, Cymbiotika charges roughly $0.0064/mg NMN versus Nutricost's $0.0018/mg. You pay 3.6x more per milligram of NMN. The question is whether the four companion ingredients and the quality verification infrastructure justify that gap.

The Apigenin Angle: Why This Ingredient Matters for an NMN Formula

Apigenin is the most scientifically interesting ingredient in Cymbiotika's formula, and also the least discussed in most reviews. Here is why it matters specifically in an NMN context.

CD38 is an enzyme that consumes NAD+. As you age, CD38 activity increases, which is one of the drivers of declining NAD+ levels. A 2013 study published in Diabetes demonstrated that apigenin is a potent inhibitor of CD38, and that CD38 inhibition by apigenin increased NAD+ levels in cell culture and in mouse tissue (Escande et al., 2013, PMID: 23172919). A 2020 study in Aging confirmed that CD38 inhibition by apigenin ameliorated mitochondrial oxidative stress in aged mice (Ogura et al., 2020, PMID: 32507768).

The logic of combining NMN (which supplies raw material for NAD+ synthesis) with apigenin (which slows NAD+ degradation via CD38 inhibition) is biochemically sound. You are adding to the supply side while reducing drain on the demand side. This is a more thoughtful formula design than simply stacking NMN with resveratrol because David Sinclair mentioned it on a podcast.

The caveat: the apigenin data is almost entirely preclinical. The Escande and Ogura studies were conducted in cell culture and mice, not in humans taking oral apigenin capsules. A 2024 review in Frontiers in Nutrition characterized apigenin as sitting "at the intersection of sleep and aging" but noted the absence of large-scale human supplementation trials (Kramer et al., 2024, PMID: 38476603). A 2023 review in Phytomedicine mapped several natural products, including apigenin, as therapeutic tools targeting NAD+ metabolism but similarly acknowledged that clinical translation remains early-stage (Guo et al., 2023, PMID: 36948143).

At 200 mg, Cymbiotika's apigenin dose is higher than most standalone apigenin supplements on the market (typically 50-100 mg). Whether this produces meaningful CD38 inhibition in humans at oral bioavailability levels is an open question that no published trial has definitively answered.

Trans-Resveratrol at 100 mg: The Sinclair Tax

Every NMN product that includes resveratrol is, to some degree, trading on the Sinclair thesis: that NMN and resveratrol work synergistically to activate sirtuins and support NAD+ dependent pathways. The data picture is more complicated than the marketing suggests.

The dose-response evidence for resveratrol in humans requires at least 150 mg daily, and most positive trials used 250-500 mg. A 2025 meta-analysis of 11 RCTs found that resveratrol supplementation produced no significant impact on SIRT1 gene expression in humans (SMD = 0.05, 95% CI -0.24 to 0.34), casting doubt on one of the central mechanisms the Sinclair thesis relies on (Mansouri et al., 2025, PMID: 40158656).

Cymbiotika's 100 mg falls below the minimum dose used in trials showing any biomarker changes. At this dose, the trans-resveratrol is better understood as an antioxidant contribution than as a sirtuin activator. This is not necessarily a problem, but it does mean the marketing framing of "NMN + Trans-Resveratrol" overrepresents what the resveratrol component is doing at this dose. For a deeper analysis of this combination, see our NMN and Resveratrol guide.

Green Tea Extract and Green Coffee Bean: The Fine Print

The remaining two ingredients deserve a brief but honest evaluation.

Green Tea Extract (200 mg, 20% L-Theanine): This provides approximately 40 mg of L-theanine per serving. A 2026 systematic review and meta-analysis in Molecular Psychiatry evaluated the cognitive and affective effects of L-theanine and found that effective doses in clinical trials typically ranged from 100-400 mg (Gerolymos et al., 2026, PMID: 42410082). At 40 mg, Cymbiotika delivers less than half the minimum effective dose identified in the literature. The green tea extract also provides catechins (EGCG), which have antioxidant properties, but the dose is modest by standalone green tea supplement standards.

Green Coffee Bean (100 mg, 10% Caffeine): This supplies approximately 10 mg of caffeine, less than what you would get from a sip of brewed coffee (a cup contains 80-100 mg). The chlorogenic acid content at this dose is also far below the 400-800 mg range evaluated in clinical trials. A 2023 systematic review found mixed evidence for green coffee bean's cardiovascular and metabolic effects at substantially higher doses (Kanchanasurakit et al., 2023, PMID: 37710316). At 100 mg of extract, this ingredient contributes negligible physiological impact. It reads as a label filler.

The Trust Premium: What SuppCo's 9.63 Actually Means

Cymbiotika's SuppCo TrustScore of 9.63 is not a measure of how well NMN works. It is a composite score reflecting manufacturing standards, third-party testing infrastructure, ingredient transparency, and certification breadth. What it tells you is that the company has invested in the kind of quality assurance systems that reduce the probability of contamination, mislabeling, or underdosing.

For context, here is how Cymbiotika's score compares to other reviewed NMN products:

Product	NMN Dose	Price/Mo	SuppCo Score	$/mg NMN
Cymbiotika NMN + Trans-Resveratrol	400 mg	$77.00	9.63 (Excellent)	$0.0064
Wonderfeel Youngr NMN	900 mg	~$88.00	8.5+ (Very Good)	$0.0033
ProHealth NMN Pro	500 mg	~$44.95	8.6 (Very Good)	$0.0030
Nutricost NMN	500 mg	~$27.16	7.9 (Good)	$0.0018
Force Factor NMN	500 mg	$24.97	7.0 (Good)	$0.0017
YourHealthier NMN	500 mg	$29.99	COA published	$0.0020

The pattern is clear: Cymbiotika scores the highest on trust verification but delivers the lowest NMN dose and the highest cost per milligram. Whether this tradeoff works for you depends on what you value more: absolute NAD+ input (in which case, higher-dose competitors win) or absolute quality assurance (in which case, Cymbiotika's verification depth is genuinely best-in-class).

What the Clinical Evidence Actually Supports at 400 mg NMN

To be fair to Cymbiotika's dose choice: 400 mg NMN is not arbitrary. It sits above the 250 mg dose that multiple trials have validated and below the 600 mg dose where the strongest NAD+ response appears. A 2025 meta-analysis of 12 NMN RCTs encompassing 513 participants confirmed that NMN supplementation reliably elevates blood NAD+ across the 250-1,000 mg dose range, though downstream metabolic effects remained inconsistent (Zhang et al., 2025, PMID: 39116016).

A 2023 review across completed human trials concluded that NMN is well-tolerated at doses up to 1,250 mg daily in short-term studies and reliably elevates blood NAD+ concentrations (Song et al., 2023, PMID: 37619764). The Fukamizu safety trial specifically evaluated 1,250 mg daily for four weeks without adverse events (Fukamizu et al., 2022, PMID: 36002548).

The 2026 Nature Metabolism study by Christen and colleagues provided the most mechanistic insight yet, showing in 65 healthy participants that NMN's NAD+ boosting effect works partly through gut microbial conversion to nicotinic acid (Christen et al., 2026, PMID: 41540253). This complexity means that individual response to any NMN dose, including Cymbiotika's 400 mg, may vary based on gut microbiome composition.

For a detailed breakdown of dose-response evidence, see our NMN dosage guide.

Who Should Consider Cymbiotika NMN

This product makes the most sense for three specific consumer profiles.

First: if you have had concerns about supplement quality and are willing to pay more for the highest level of manufacturing and testing verification available in the NMN category. Cymbiotika's ISO 17025 + NSF certification combination is a genuine differentiator that most competitors lack.

Second: if you specifically want an NMN product with apigenin as a CD38 inhibitor. The biochemical logic of this combination is sound even though the human evidence is early. You would be hard-pressed to find another NMN product with 200 mg standardized apigenin at 98% purity.

Third: if you are already a Cymbiotika customer and trust the brand ecosystem. The HSA/FSA eligibility is a practical benefit, and brand consolidation (buying multiple supplements from one trusted manufacturer) is a reasonable strategy.

What Consumer Reviews Actually Reveal

Cymbiotika's NMN product carries 878 reviews averaging 4.9 stars on the brand's website. Like any DTC supplement with an on-site review system, this should be read with context. Brands control which reviews are displayed, and self-selected reviewers skew toward people who already trust the brand enough to buy a $77 supplement.

Even so, some patterns in consumer feedback are worth noting. The most frequently cited positive effects are improved energy and perceived skin quality, both within 2-4 weeks. Several reviewers mention stacking Cymbiotika NMN with the brand's Liposomal B12, following the "pro-tip" suggestion on the product page. The most common complaint is price, with multiple reviewers noting they switched from higher-dose, cheaper NMN products specifically for Cymbiotika's brand trust and certifications.

One recurring theme worth flagging: some reviewers attribute benefits to specific companion ingredients ("I can feel the apigenin helping my sleep") that cannot be isolated from placebo response in an uncontrolled self-experiment. The presence of green coffee bean extract's 10 mg caffeine could produce a mild energizing effect that gets attributed to "NMN working," and the L-theanine, even at sub-clinical doses, may contribute to a calming sensation that reviewers associate with improved wellbeing. These are real experiences, but they do not constitute evidence for the individual ingredient claims.

NMN Source and Manufacturing Transparency

Cymbiotika does not publicly disclose the specific NMN raw material supplier or manufacturer name. What it does disclose is the certification infrastructure: ISO 17025-accredited third-party testing (meaning the testing lab itself meets international standards for competence), NSF-certified manufacturing (meaning the production facility meets NSF International's GMP standards), and a "View Full PDF" link on the product page directing to test results. This is more disclosure than most NMN brands provide.

For comparison, ProHealth Longevity names its NMN supplier (Uthever by EffePharm) and publishes batch-specific COAs. Wonderfeel also discloses its manufacturing partner and publishes COAs. Cymbiotika sits in between: more transparent than generic Amazon sellers like NMN Beta products, but less specifically transparent than brands that name their NMN source.

The SuppCo notation that "product-specific testing is not currently verified by SuppCo" is worth attention. This means SuppCo has not independently purchased and tested a bottle of Cymbiotika NMN to confirm the label matches the contents. The 9.63 score reflects verified manufacturing and testing infrastructure, not a verified bottle. This distinction matters: a factory can be NSF-certified while individual product runs vary in quality. No SuppCo-verified independent test of the finished product has been published.

The Cost Equation: What $77 Actually Buys

To understand whether Cymbiotika represents value, it helps to price out the components individually.

If you bought each ingredient separately at comparable quality levels, a 30-day supply would cost approximately: 500 mg NMN from a COA-verified brand (~$30), standalone apigenin 200 mg (~$12-15 for 30 days), trans-resveratrol 250 mg from a 98% standardized source (~$10-15), and L-theanine 200 mg (~$8-10). The green coffee bean at such a low dose would add negligible cost. Total: roughly $60-70 for higher individual doses of each ingredient (500 mg NMN instead of 400 mg, 250 mg resveratrol instead of 100 mg, 200 mg L-theanine instead of 40 mg).

Cymbiotika at $77 delivers lower doses of each component in a single capsule with superior manufacturing verification. The convenience premium exists, but the dose discount is real. This is a common pattern in multi-ingredient supplements: the formulation convenience comes at the cost of sub-optimal individual dosing. Whether that tradeoff works for you depends on whether you would realistically buy and take 4-5 separate supplements daily. Most people would not.

Who Should Look Elsewhere

If you want the highest NMN dose per dollar, Cymbiotika is the wrong product. You can get 25% more NMN at less than half the price from multiple reviewed competitors. If resveratrol at a clinical dose matters to you, Cymbiotika's 100 mg is not enough. Consider a standalone resveratrol supplement at 250+ mg alongside a pure NMN product. If cost is a constraint, budget NMN options like Nutricost or Force Factor deliver the core molecule at a fraction of the cost with reasonable (though less exhaustive) quality verification.

For a ranked comparison of all NMN products we have reviewed, see our Best NMN Supplements (2026) guide.

Long-Term Cost of Cymbiotika NMN: A 12-Month View

NMN is not a short-term supplement. The premise of NAD+ replenishment assumes sustained, daily use over months or years. This makes the long-term cost the most relevant financial metric, not the per-bottle price.

At $77/month, a year of Cymbiotika NMN costs $924 at retail, or $831.60 with the subscription discount (~$69.30/month). Over the same 12 months, Nutricost NMN at subscription pricing (~$27.16/month) costs $325.92, and Force Factor at $24.97/month costs $299.64. YourHealthier NMN at $29.99/month costs $359.88. These differences compound significantly over a multi-year supplementation commitment.

The annual cost difference between Cymbiotika and a budget NMN brand is approximately $500-600. That budget could alternatively fund: a standalone apigenin supplement at a proper dose for the full year (~$150), a standalone resveratrol supplement at 250 mg for the full year (~$120), a higher-dose NMN product for the full year (~$350), and still leave change. In other words, for less money than Cymbiotika alone, you could build a custom stack with higher individual doses of every ingredient Cymbiotika includes.

The counterargument is effort and consistency. A five-bottle daily stack has five points of failure (forgotten doses, reorder timing, storage requirements). A single Cymbiotika two-capsule serving simplifies compliance. For consumers who value simplicity above dosing optimization, this is a legitimate benefit, just one that comes at a substantial premium.

Safety at This Formulation

NMN at 400 mg is well within the safety-tested range. Human trials have evaluated NMN at doses up to 1,250 mg daily for four weeks without significant adverse events (Fukamizu et al., 2022, PMID: 36002548). A detailed safety review spanning multiple completed human trials found consistent tolerability across the 250-1,250 mg range (Song et al., 2023, PMID: 37619764). For a full discussion of potential side effects at various doses, see our NMN side effects guide.

Apigenin at 200 mg is generally well-tolerated. It is a naturally occurring flavonoid present in chamomile tea, parsley, and celery. However, apigenin can interact with certain medications due to its effects on cytochrome P450 enzymes (the same enzyme family that grapefruit juice affects). If you are taking prescription medications, particularly blood thinners, sedatives, or drugs metabolized by CYP3A4, consult a healthcare provider before adding an apigenin-containing supplement.

The 10 mg caffeine from green coffee bean extract is too low to cause stimulant-related side effects in nearly all adults. However, individuals with diagnosed caffeine sensitivity or those who strictly avoid all caffeine should note its presence.

Trans-resveratrol at 100 mg has been extensively evaluated in human trials at much higher doses (up to 5,000 mg daily) without serious adverse effects, though gastrointestinal discomfort can occur at high doses. At 100 mg, gastrointestinal effects are unlikely.

Where Cymbiotika Fits in the NMN Market Landscape

The NMN market has stratified into four tiers by mid-2026:

Budget tier ($0.80-$1.10/day): Brands like Force Factor, Nutricost, and generic Amazon NMN Beta sellers compete on price with 500 mg single-ingredient formulas. Verification varies widely from ISO-claimed but unpublished COAs (Nutricost) to no verification at all (most Amazon generics).

Mid-tier ($1.30-$1.70/day): Brands like ProHealth Longevity and YourHealthier offer verified NMN (named raw material sources, published COAs) at moderate prices. This tier prioritizes ingredient verification over formula complexity.

Premium multi-ingredient ($2.50-$3.00/day): This is where Cymbiotika sits, alongside Wonderfeel Youngr and Omre NMN + Resveratrol. These products bundle NMN with companion ingredients and justify higher prices through brand positioning, certification depth, or formula design.

Ultra-premium ($3.50+/day): Brands like DoNotAge offer high-dose NMN powder (1,000 mg+ daily) with Uthever-certified raw material at high total cost but competitive per-milligram pricing. These target longevity enthusiasts who prioritize dose above all else. A separate emerging category is reduced NMN (NMNH), which some brands market as a more potent precursor, though the human evidence remains far thinner than for standard NMN, as we cover in our NMNH vs NMN comparison.

Cymbiotika occupies the premium tier with the strongest verification credentials but the weakest NMN dose within its price class. This is a conscious brand strategy: Cymbiotika is not trying to win on NMN content but on trust infrastructure. Whether that strategy aligns with your supplementation goals depends on whether you view NMN as a commodity input (in which case, buy the cheapest verified source at 500 mg) or as a product where manufacturing quality justifies a premium (in which case, Cymbiotika's verification depth is genuinely unmatched in the category).

Frequently Asked Questions

Is 400 mg of NMN enough?

Yes, 400 mg falls within the clinically tested range. Multiple human trials have demonstrated meaningful NAD+ elevation at 250 mg daily (Yoshino et al., 2021, PMID: 33888596). However, dose-ranging data suggests that 600 mg produces a stronger NAD+ response per milligram (Yi et al., 2023, PMID: 36482258). At 400 mg, you are getting a clinically relevant dose but not maximizing the dose-response curve. For an in-depth analysis, see our NMN dosage guide.

Why is Cymbiotika NMN so expensive?

The price reflects brand positioning, not ingredient cost. Cymbiotika maintains ISO 17025-accredited third-party testing, NSF-certified manufacturing, USDA Organic certification, and Non-GMO verification. These certifications are expensive to obtain and maintain. However, you can get verified NMN at 500 mg for under $30/month from multiple brands with third-party testing. You are paying a trust premium, not a dose premium.

Does apigenin in Cymbiotika NMN actually help with NAD+ levels?

The theory is strong. Apigenin inhibits CD38, an enzyme that degrades NAD+, meaning it could help preserve the NAD+ that NMN generates (Escande et al., 2013, PMID: 23172919). However, this has been demonstrated in cell culture and animal models, not in a human trial testing oral apigenin at this dose. The inclusion is scientifically rational but clinically unproven.

Is Cymbiotika NMN better than Wonderfeel Youngr?

Wonderfeel Youngr delivers 900 mg NMN (2.25x Cymbiotika's dose) with trans-resveratrol, ergothioneine, hydroxytyrosol, and vitamin D3 for ~$88/month. Cymbiotika delivers less NMN (400 mg) with different companion ingredients (apigenin, green tea, green coffee bean) for $77/month. Wonderfeel offers more NMN per dollar and a broader antioxidant formula. Cymbiotika offers higher SuppCo verification and the unique apigenin-CD38 angle. Neither is objectively "better"; they serve different priorities.

Does Cymbiotika NMN have caffeine?

Yes, but barely. The green coffee bean extract contains 10% caffeine, which translates to approximately 10 mg per two-capsule serving. For reference, a cup of coffee contains 80-100 mg. Most people will not notice any stimulant effect at this dose. If you are extremely caffeine-sensitive, be aware it is present, but at a physiologically trivial amount.

Should I take Cymbiotika NMN with TMG?

Unlike Dr. Love NMN (which includes 400 mg TMG in its formula), Cymbiotika does not contain TMG. If methylation support is important to you, adding a standalone TMG supplement at 500-3,000 mg daily is an option. See our NMN guide for a discussion of the methylation question.

References

1. Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. PMID: 33888596
2. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. NPJ Aging. 2022;8(1):5. PMID: 35927255
3. Yi L, Maier AB, Tao R, et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. Geroscience. 2023;45(1):29-43. PMID: 36482258
4. Escande C, Nin V, Price NL, et al. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013;62(4):1084-1093. PMID: 23172919
5. Ogura Y, Kitada M, Xu J, et al. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats. Aging. 2020;12(12):11325-11336. PMID: 32507768
6. Kramer DJ, Johnson AA. Apigenin: a natural molecule at the intersection of sleep and aging. Front Nutr. 2024;11:1359176. PMID: 38476603
7. Guo C, Ding G, Huang W, et al. Therapeutic application of natural products: NAD+ metabolism as potential therapeutic target. Phytomedicine. 2023;114:154768. PMID: 36948143
8. Mansouri F, et al. Impact of resveratrol supplementation on human sirtuin 1 gene expression: a systematic review and meta-analysis. J Acad Nutr Diet. 2025. PMID: 40158656
9. Song Q, Zhou X, Xu K, et al. The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: an update. Adv Nutr. 2023;14(6):1416-1435. PMID: 37619764
10. Fukamizu Y, Uchida Y, Shigekawa A, et al. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep. 2022;12(1):14442. PMID: 36002548
11. Christen S, Cuenoud B, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026. PMID: 41540253
12. Zhang J, Poon ETC, Wong SHS, et al. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism: a systematic review with meta-analysis. Crit Rev Food Sci Nutr. 2025. PMID: 39116016
13. Gerolymos C, et al. Cognitive and affective effects of L-Theanine: a systematic review and meta-analysis. Mol Psychiatry. 2026. PMID: 42410082
14. Kanchanasurakit S, Saokaew S, Piriyachananusorn N, et al. Chlorogenic acid in green bean coffee on body weight: a systematic review and meta-analysis. Syst Rev. 2023;12(1):163. PMID: 37710316

Disclaimer: This article is for informational purposes only and does not constitute medical advice. NMN supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before beginning any supplement regimen.